Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells

Advances in Experimental Medicine and Biology

Volumn 476, Issue , 2000, Pages 7-34

  Presta, M ^a   Rusnati, M ^a   Dell'Era, P ^a   Tanghetti, E ^a   Urbinati, C ^a   Giuliani, R ^a   Leali, D ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Angiogenesis; Endothelium; FGF2; Heparin; Signal transduction; Transfection

Indexed keywords

CYTOKINE; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; GROWTH FACTOR; HEPARIN DERIVATIVE; PROTEOHEPARAN SULFATE;

ANGIOGENESIS; AUTOCRINE EFFECT; CAPILLARY; CELL PROLIFERATION; CELL SURFACE; CONFERENCE PAPER; ENDOTHELIUM; EXTRACELLULAR MATRIX; GENETIC TRANSFECTION; NEOVASCULARIZATION (PATHOLOGY); PARACRINE SIGNALING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0034470220     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-4221-6_2     Document Type: Conference Paper

References (113)

1. Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor
2. Angiogenic potential in vivo by Kaposi sarcoma cell-free supernatants and HIV1-tat product: Inhibition of KS-like lesions by TIMP-2
3. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo
4. Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor
5. Immunoreactive fibroblast growth factor (FGF) in a transplantable chondrosarcoma: Inhibition of tumor growth by antibodies to FGF
6. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression
7. The FGF family of growth factors and oncogenes
8. + T cells
9. A structure-activity analysis of antagonism of the growth factor and angiogenic activity of basic fibroblast growth factor by suramin and related polyanions
10. The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis
11. Monospecific antibodies implicate basic fibroblast growth factor in normal wound repair
12. Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer
13. New sulfonated distamycin A derivatives with bFGF complexing activity
14. Different effects of mucosal, bovine lung and chemically modified heparin on selected biological properties of basic fibroblast growth factor
15. Growth advantage and vascularization induced by basic fibroblast growth factor overexpression in endometrial HEC-1-B cells: An export-dependent mechanism of action
16. Cytokine-mediated control of endothelial cell growth: Interferon-α and interleukin-2 synergistically enhance basic fibroblast growth factor synthesis and induce release promoting cell growth in vitro and in vivo
17. A secreted FGF-binding protein can serve as the angiogenic switch in human cancer
18. Fibroblast growth factor in the extracellular matrix of dystrophic (mdx) mouse muscle
19. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma
20. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS
21. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy
22. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells
23. Antiproliferative and angiostatic activity of suramin analogues
24. Human basic fibroblast growth factor gene encodes four polypeptides: Three initiate translation from non-AUG codons
25. A heparin-binding angiogenic protein-basic fibroblast growth factor- is stored within basement membran
26. Inhibition of angiogenesis by suramin
27. Inhibition of angiogenesis by aurintricarboxylic acid
28. Injury-induced release of basic fibroblast growth factor from bovine aortic endothelium
29. Internalization of basic fibroblast growth factor by chinese hamster lung fibroblast cells: Involvement of several pathways
30. Heparin can activate a receptor tyrosine kinase
31. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels
32. Effects of modulation of basic fibroblast growth factor on tumor growth in vivo
33. Interaction of high molecular weight basic fibroblast growth factor (bFGF) with endothelium: Biological activity and intracellular fate of human recombinant Mr 24,000 bFGF
34. Basic fibroblast growth factor overexpression in endothelial cells: An autocrine mechanism for angiogenesis and angioproliferative diseases
35. Angiogenic phenotype induced by basic fibroblast growth factor transfection in brain microvascular endothelial cells: An in vitro autocrine model of angiogenesis in brain tumors
36. Activating and inhibitory, heparin sequences for FGF-2 (basic FGF)
37. bFGF as an autocrine growth factor for human melanomas
38. Tyrosine kinase inhibitors impair fibroblast growth factor signaling in coronary endothelial cells
39. In vitro and in vivo inhibition of ortho- and paramyxovirus infections by a new class of sulfonic acid polymers interacting with virus-cell binding and/or fusion
40. Preparation of affinity-fractionated, heparin-derived oligosaccharides and their effects on selected biological activities mediated by basic fibroblast growth factor
41. Specific blockade of basic fibroblast growth factor gene expression in endothelial cells by antisense oligonucleotide
42. Structural and functional diversity in the FGF receptor multigene family
43. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma
44. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo
45. An essential heparin-binding domain in the fibroblast growth factor receptor kinase
46. Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells
47. Microvascular corrosion casting in the study of tumor vascularity: A review
48. Impact of fibroblast growth factor-2 on tumor microvascular architecture. A tridimensional morphometric study
49. AIDS-related malignancies: The emerging epidemic
50. Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumors
51. The sulfonic acid polymers PAMPS [poly(acrylamido-2-methyl-1-propanesulfonic acid)] and related analogues are highly potent inhibitors of angiogenesis
52. Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds
53. A simple and accurate method for 3-D measurements in microcorrosion casts illustrated with tumor vascularization
54. VEGF-mediated tumour angiogenesis: A new target for cancer therapy
55. Growth factors are released by mechanically wounded endothelial cells
56. Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling and angiogenic activity by a synthetic heparin-mimicking polyanionic compound
57. In vitro angiogenesis on the human amniotic membrane: Requirement for basic fibroblast growth factor
58. Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor
59. Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an autocrine manner
60. Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex
61. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-mutant
62. Basic fibroblast growth factor induces angiogenesis in vitro
63. Both normal and tumor cells produce basic fibroblast growth factor
64. Sulphonic acid polymers as a new class of human immunodeficency virus inhibitors
65. Suramin: A novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancer
66. Basic fibroblast growth factor in human prostate cancer cells
67. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers
68. Basic-fibroblast-growth-factor-mediated de novo angiogenesis is more effetively suppressed by low-molecular weight than by high-molecular-weight heparin
69. Immunocytochemical localization of basic fibroblast growth factor in carcinomas and inflammatory lesions of the human digestive tract
70. C6 glioma cells produce basic fibroblast growth factor that can stimulate their own proliferation
71. Basic fibroblast growth factor increases junctional communication and connexin 43 expression in microvascular endothelial cells
72. Upregulation of urokinase receptor expression on migrating endothelial cells
73. Tumor cells secrete an angioganic factor that stimulates basic fibroblast growth factor and urokinase expression in vascular endothelial cells
74. Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration
75. Basic fibroblast growth factor: Production, mitogenic response, and post-receptor signal transduction in cultured normal and transformed fetal bovine aortic endothelial cells
76. Purine analogue 6-methylmercaptopurine riboside inhibits early and late phases of the angiogenesis process
77. bFGF and tumor angiogenesis - Back in the limelight?
78. Endogenous basic fibroblast growth factor in the vascularization of the chick embryo chorioallantoic membrane
79. Fibroblast growth factor-2 can mdiate cell attachment by linking receptors and heparan sulfate proteoglycans on neighboring cells
80. Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells and the differentiation of PC12 cells
81. Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms
82. Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: Role of the low affinity heparin-like bFGF receptors
83. Distinct role of 2-O-, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1
84. Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans
85. A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells
86. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence
87. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors
88. Autocrine activities of basic fibroblast growth factor: Regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis
89. In situ detection of basic fibroblast growth factor by highly specific antibodies
90. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth
91. Acid and basic fibroblast growth factors in adult rat heart myocytes: Localization, regulatio in culture, and effects on DNA synthesis
92. Basic fibroblast growth factor in human pheochromocytoma: A biochemical and immunohistochemical study
93. Kaposi's sarcoma: A review of gene expression and ultrastructure of KS spindle cells in vivo
94. Gene expression of fibroblast growth factors in human gliomas and meningiomas: Demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues
95. Cellular markers that distinguish the phases of hemangioma during infancy and childhood
96. Significance of vessel count and vascular endothelial growth factor ant its receptor (KDR) in intestinal-type gastric cancer
97. Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation and induction of urokinase-type plasminogen activator
98. Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases
99. Comparison of several antiangiogenic regimens alone and with cytotoxic therapies in the Lewis lung carcinoma
100. Heparan sulfate: Functional role as modulator of fibroblast growth factor activity
101. Endothelial cell-derived basic fibroblast growth factor: Synthesis and deposition into subendothelial extracellular matrix
102. Aortic endothelial cells synthesize basic fibroblast growth factor which remains cell associated and platelet-derived growth factor-like protein which is secreted
103. Suramin inhibits growth of human osteosarcoma xenografts in nude mice
104. Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth
105. Transcriptional regulation of basic fibroblast growth factor gene expression in capillary endothelial cells
106. Effects of irradiation on the release of growth factors from cultured bovine, porcine, and human endothelial cells
107. Immunohistochemical localization of basic fibroblast growth factor in astrocytomas
108. Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF
109. Inhibition by pentosan polysulfate (PPS) of heparin-binding growth factors released from tumor cells and blockage by PPS of tumor growth in animals, 1992
110. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage
111. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor
112. An autocrine model for cell-associated and matrix-associated fibroblast growth factor